Detalles de la búsqueda
1.
Final outcomes analysis of the cell product SQZ-PBMC-HPV Phase 1 trial in incurable HPV16+ solid tumors shows improved overall survival in patients with increased CD8+ T cell tumor infiltration.
Mol Carcinog
; 2024 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38695604
2.
Phase 1 study to determine the safety and dosing of autologous PBMCs modified to present HPV16 antigens (SQZ-PBMC-HPV) in HLA-A*02+ patients with HPV16+ solid tumors.
Invest New Drugs
; 41(2): 284-295, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36867316
3.
Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent Chemoradiotherapy.
Chemotherapy
; 68(1): 35-43, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-35882207
4.
A Critical Appraisal and Targeted Intervention of the Oncology Experience in an Internal Medicine Residency.
J Cancer Educ
; 36(6): 1290-1294, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32445119
5.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.
Lancet
; 394(10212): 1915-1928, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31679945
6.
Palbociclib and cetuximab in platinum-resistant and in cetuximab-resistant human papillomavirus-unrelated head and neck cancer: a multicentre, multigroup, phase 2 trial.
Lancet Oncol
; 20(9): 1295-1305, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31351869
7.
Clinical Outcomes of Different Treatment Modalities in Anaplastic Thyroid Cancer: A Single Center Experience.
Am J Ther
; 29(6): e714-e716, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-32889810
8.
Impact of Adjuvant Radiotherapy Setting on Quality-of-Life in Head and Neck Squamous Cell Carcinoma.
Laryngoscope
; 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38436503
9.
Prognostic Implications of Skin Invasion in Locally Advanced Oral Cavity Squamous Cell Carcinoma.
Otolaryngol Head Neck Surg
; 169(1): 69-75, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35917167
10.
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
J Clin Oncol
; 41(4): 790-802, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36219809
11.
Spontaneous Regression of the Pulmonary Metastases in Adenoid Cystic Carcinoma of the Parotid Gland: A Case Report.
Cureus
; 14(10): e30783, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36447731
12.
Sarcopenia and Treatment Toxicity in Older Adults Undergoing Chemoradiation for Head and Neck Cancer: Identifying Factors to Predict Frailty.
Cancers (Basel)
; 14(9)2022 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565223
13.
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048.
Oral Oncol
; 128: 105815, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381576
14.
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score.
J Clin Oncol
; 40(21): 2321-2332, 2022 07 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35333599
15.
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Clin Cancer Res
; 28(23): 5040-5048, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36194164
16.
Glomangiomyoma of Uncertain Malignant Potential in the Urinary Bladder: A Case Report.
JNMA J Nepal Med Assoc
; 59(239): 719-722, 2021 Jul 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34508517
17.
Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review.
Front Oncol
; 11: 642110, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33816289
18.
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.
Med Oncol
; 38(4): 35, 2021 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33683482
19.
Reliance on Self-Medication Increase Delays in Diagnosis and Management of GI Cancers: Results From Nepal.
JCO Glob Oncol
; 6: 1258-1263, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32762562
20.
Randomized Phase II Trial to Compare the Efficacy of Haloperidol and Olanzapine in the Control of Chemotherapy-Induced Nausea and Vomiting in Nepal.
J Glob Oncol
; 5: 1-6, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31013182